Evidence map›Paper›PMID 28212677›Full record

ArticleSystematic reviews2017

Fit for purpose: perspectives on rapid reviews from end-user interviews.

Lisa Hartling, Jeanne-Marie Guise, Susanne Hempel, Robin Featherstone, Matthew D Mitchell, Makalapua L Motu'apuaka, Karen A Robinson, Karen Schoelles, Annette Totten, Evelyn Whitlock and 7 more

Abstract read
In one paragraph

Article in Systematic reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Lisa HartlingDepartment of Pediatrics, University of Alberta, ECHA 4-472, 11405-87 Avenue, Edmonton, Alberta, T6G 1C9, Canada. Hartling@ualberta.ca.ORCID 0000-0001-8341-3991
Jeanne-Marie GuiseScientific Resource Center for the AHRQ Effective Health Care Program, Portland VA Research Foundation, 3710 SW U.S. Veterans Hospital Road, Portland, OR, 97239, USA.
Susanne HempelEvidence-based Practice Center, RAND Corporation, 1776 Main Street, Santa Monica, CA, 90407, USA.
Robin FeatherstoneAlberta Research Center for Health Evidence, University of Alberta, Edmonton Clinic Health Academy 4-486D, 11405-87 Avenue, Edmonton, Alberta, T6G 1C9, Canada.
Matthew D MitchellECRI-Penn AHRQ Evidence-based Practice Center, University of Pennsylvania Health System, 3535 Market St. Suite 50, Philadelphia, PA, 19104, USA.
Makalapua L Motu'apuakaScientific Resource Center for the AHRQ Effective Health Care Program, Portland VA Research Foundation, 3710 SW U.S. Veterans Hospital Road, Portland, OR, 97239, USA.
Karen A RobinsonDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Karen SchoellesECRI Institute, 5200 Butler Pike, Plymouth Meeting, PA, 19462, USA.
Annette TottenPacific Northwest Evidence-based Practice Center, 3181 SW Sam Jackson Park Rd, Portland, OR, 97239, USA.
Evelyn WhitlockKaiser Permanente Research Affiliates Evidence-based Practice Center, Center for Health Research, Kaiser Permanente Northwest, 3800N. Interstate Ave, Portland, OR, 97227, USA.
Timothy J WiltMinnesota Evidence-based Practice Center, Minneapolis VA Center for Chronic Disease Outcomes Research and the University of Minnesota, 1 Veterans Drive, 111-0, Minneapolis, MN, 55417, USA.
Johanna AndersonScientific Resource Center for the AHRQ Effective Health Care Program, Portland VA Research Foundation, 3710 SW U.S. Veterans Hospital Road, Portland, OR, 97239, USA.
Elise BerlinerAgency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD, 20857, USA.
Aysegul GozuAgency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD, 20857, USA.
Elisabeth KatoAgency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD, 20857, USA.
Robin PaynterScientific Resource Center for the AHRQ Effective Health Care Program, Portland VA Research Foundation, 3710 SW U.S. Veterans Hospital Road, Portland, OR, 97239, USA.
Craig A UmscheidCenter for Evidence-based Practice, University of Pennsylvania, 3535 Market Street, Mezzanine, Suite 50, Philadelphia, PA, 19104, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is increasing demand for rapid reviews and timely evidence synthesis. The goal of this project was to understand end-user perspectives on the utility and limitations of rapid products including evidence inventories, rapid responses, and rapid reviews.

methodsInterviews were conducted with key informants representing: guideline developers (n = 3), health care providers/health system organizations (n = 3), research funders (n = 1), and payers/health insurers (n = 1). We elicited perspectives on important characteristics of systematic reviews, acceptable methods to streamline reviews, and uses of rapid products. We analyzed content of the interview transcripts and identified themes and subthemes.

resultsKey informants identified the following as critical features of evidence reviews: (1) originating from a reliable source (i.e., conducted by experienced reviewers from an established research organization), (2) addressing clinically relevant questions, and (3) trusted relationship between the user and producer. Key informants expressed strong preference for the following review methods and characteristics: use of evidence tables, quality rating of studies, assessments of total evidence quality/strength, and use of summary tables for results and conclusions. Most acceptable trade-offs to increase efficiencies were limiting the literature search (e.g., limiting search dates or language) and performing single screening of citations and full texts for relevance. Key informants perceived rapid products (particularly evidence inventories and rapid responses) as useful interim products to inform downstream investigation (e.g., whether to proceed with a full review or guideline, direction for future research). Most key informants indicated that evidence analysis/synthesis and quality/strength of evidence assessments were important for decision-making. They reported that rapid reviews in particular were useful for guideline development on narrow topics, policy decisions when a quick turn-around is needed, decision-making for practicing clinicians in nuanced clinical settings, and decisions about coverage by payers/health insurers. Rapid reviews may be more relevant within specific clinical settings or health systems; whereas, broad/national guidelines often need a traditional systematic review.

conclusionsKey informants interviewed in our study indicated that evidence inventories, rapid responses, and rapid reviews have utility in specific decisions and contexts. They indicated that the credibility of the review producer, relevance of key questions, and close working relationship between the end-user and producer are critical for any rapid product. Our findings are limited by the sample size which may have been too small to reach saturation for the themes described.

Indexed as

Review Literature as TopicDelivery of Health CareEvidence-Based MedicineHealth PersonnelHumansInsurance, HealthInterviews as TopicTime FactorsDecision-makersEnd-usersInterviewsKnowledge synthesisRapid reviewsSystematic reviews

Identifiers

PMID28212677
PMCPMC5316162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.